RENOWN SOUTH MEADOWS MED CTR — History
CCN 290049 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$91M
Latest Revenue (FY2022)
-22.8%
Revenue CAGR (3yr)
4.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $153M | $168M | $91M | -45.9% | -22.8% |
| Operating Expenses | $141M | $158M | $87M | -44.6% | -21.2% |
| Operating Margin | 7.9% | 6.3% | 4.0% | -36.5% | -29.2% |
| Net Income | $12M | $11M | $4M | -65.6% | -45.4% |
| Licensed Beds | 76 | 76 | 78 | +2.6% | +1.3% |
| Total Patient Days | 17,078 | 15,970 | 8,688 | -45.6% | -28.7% |
| Medicare Day % | 36% | 36% | 38% | +4.3% | +2.3% |
| Medicaid Day % | 5% | 7% | 5% | -24.4% | +1.1% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -40.4% ($153M → $91M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-22.8%
This Hospital
+7.6%
State Avg
Latest Margin
4.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $60M | 2.0% |
| FY2024 (proj) | $29M | 0.0% |
| FY2025 (proj) | $-2M | -2.0% |